20 Microns Ltd Q3 FY26 Earnings Analysis

- The company anticipates recovery in demand in the second half of FY26, driven by festive and wedding seasons and infrastructure upgrades. - Targeted revenue growth rate is 13% for the full year, despite a dip in Q2 sales. - Expects decent performance in Q3 and Q4 compared to the first half, aiming to achieve the annual revenue targets. - Export markets including Poland, Latin America, Middle East, and South Africa are starting to yield results, offsetting some saturation in Western Europe. - Focus on accelerating growth in value-added segments and speciality chemicals to enhance margins and reduce cyclicality. - Growth in polymers, rubber, and specialty segments is expected, supported by product innovation and market penetration. - Strategic R&D and customer engagement aim to capture higher value market segments and steady revenue expansion. - CapEx investments planned to support capacity growth, although some outflows have been deferred.

- Management expects to improve operations, margins, and revenues in upcoming quarters, aiming for good results by the end of FY26. (Page 17, 32:28–32:49) - EBITDA margins are projected to remain steady between 13-15%, with current levels around 13.7%. Margins may slightly fluctuate based on demand and product mix. (Page 15, 27:50–28:43; Page 8, 15:11–15:49) - Despite short-term revenue pressures and challenging demand, the company focuses on margin improvement, product diversification, and market expansion to deliver sustained value. (Page 6, 10:55–11:20) - Q2 EBITDA improved by 3.4% YoY and margins expanded by 100 bps; EPS increased from 4.65 to 4.92, indicating consistent value creation. (Page 2, Nihad Baluch's remarks) - Paint industry demand expected to recover in H2 FY26 supported by festive/wedding seasons, aiding revenue growth. (Page 4, 8:01–8:22; Page 5, 9:44–9:59) - New product launches and growth in specialty chemicals and plastics segments are anticipated to underpin future earnings growth. (Page 10, 18:28–18:58)

- The planned CapEx of ₹100 crore has been slightly deferred due to lowered demand. - Malaysian CapEx plan is on track, focusing on expanding calcium carbonate operations post-acquisition. - Fund infusion into the Malaysian subsidiary for capacity expansion is finalized and progressing. - Revision of the overall CapEx plan is underway, with updated details expected in a forthcoming press release by the CFO. - CapEx outflows are expected to resume smoothly from Q4 FY26 onwards. - Sustainability and renewal investments are ongoing and taken seriously with in-house audits and sustainability initiatives. - The company continues to invest in capacity enhancement and modernization to support growth as demand revives. - Strategic focus remains on innovation-led growth, product diversification, and market expansion to drive long-term value.

- There is no explicit mention of any new fundraising through debt or equity in the transcript. - The company has a CapEx plan of ₹100 crore, which has been slightly deferred due to lower demand. - Revised CapEx plans will be announced in the coming months through a press release. - The focus remains on operational efficiency, margin improvement, product diversification, and market expansion. - No specific references to plans for raising funds through equity or debt were made during the call.

The transcript does not explicitly mention the current or expected order book or pending orders for 20 Microns Limited. However, some related insights can be inferred: - Demand in key segments like paint and construction chemicals faced softness due to extended monsoons and subdued customer activity but is expected to recover in the second half with festive and wedding season demand. - Improved enquiries and traction post industry exhibitions suggest a pickup in orders, especially in international markets. - The company expects growth in value-added and specialty chemicals segments, which may translate to firm order inflows. - CapEx expansion plans—especially in Malaysia—are on track, indicating confidence in future order growth. - Overall, early signs of recovery and stable margins imply a cautiously optimistic order pipeline ahead but no specific order book figures were disclosed.